Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment

TGFβ (transforming growth factor-beta) is a pleotropic cytokine with contrasting effects in cancer. In normal tissue and early tumours, TGFβ acts as a tumour suppressor, limiting proliferation and inducing apoptosis. John Marshall discusses the role of TGFβ in cancer, the role of integrins in activating TGFβ in the TME, and the potential benefits of targeting integrins to augment immunotherapies.

Read the Study

Image courtesy of interviewee

Leave a Reply

Your email address will not be published.

Guest visitors to the Faculti website can view any insight monthly. You have insight(s) remaining for this month or Register for free as an individual and view thousands of insights in our archive today or subscribe for subject access.

You may already have unlimited institutional access to Faculti. Many colleges and universities have institutional memberships. If you are affiliated with a subscribing institution, please access this site through your SSO/EZproxy/IP address. This should permit you with unlimited views. However, you will not be able to view non-subscribed to content.

Copyright © Faculti Media Limited 2022. All rights reserved.

Add the Faculti Web App to your Mobile or Desktop homescreen